Volume | 0 |
|
|||||
Actualités | - | ||||||
Maximum Haut | Bas Haut |
||||||
Minimum Bas |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Jasper Therapeutics Inc | JSPR | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
23,95 |
Transactions Totales | Volume échangé | Volume en moyenne | Sur 52 semaines |
---|---|---|---|
0 | 0 | - | 4,00 - 31,01 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
- | 0 | US$ 23,95 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
360,78M | 15,06M | - | 0 | -64,47M | -4,28 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Jasper Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
05/3/2024 | 22:52 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
05/3/2024 | 22:02 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
04/3/2024 | 13:40 | Edgar (US Regulatory) | Form 8-K - Current report |
21/2/2024 | 01:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
21/2/2024 | 01:22 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
10/2/2024 | 02:36 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
06/2/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
02/2/2024 | 15:50 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
04/1/2024 | 12:04 | Edgar (US Regulatory) | Form 8-K - Current report |
02/1/2024 | 14:05 | Edgar (US Regulatory) | Form 8-K - Current report |
20/12/2023 | 12:06 | Edgar (US Regulatory) | Form 8-K - Current report |
20/11/2023 | 23:11 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
Forum Action Jasper Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Jasper Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 25,04 | 26,835 | 23,53 | 25,33 | 124 902 | -1,09 | -4,35% |
1 mois | 20,61 | 26,835 | 20,60 | 24,18 | 100 349 | 3,34 | 16,21% |
3 mois | 24,54 | 31,01 | 20,15 | 25,06 | 83 869 | -0,59 | -2,40% |
6 mois | 5,292 | 31,01 | 4,00 | 9,95 | 302 609 | 18,66 | 352,57% |
1 an | 15,90 | 31,01 | 4,00 | 9,81 | 320 734 | 8,05 | 50,63% |
3 ans | 140,60 | 188,80 | 3,862 | 56,50 | 794 652 | -116,65 | -82,97% |
5 ans | 140,60 | 188,80 | 3,862 | 56,50 | 794 652 | -116,65 | -82,97% |